LDLR and Hypercholesterolemia: Furthermore, the altered gut microbiota and ω-MCA levels activated the hepatic FXR-LDLR/ABCG5/8 pathway, promoting cholesterol excretion into feces and thereby alleviating hypercholesterolemia.